Acute promyelocytic leukemia

2Citations
Citations of this article
85Readers
Mendeley users who have this article in their library.
Get full text

Abstract

Acute promyelocytic leukemia (APL) is designated M3 in the French-American-British (FAB) classification. Because of its unique clinical features and unique response to certain differentiation-inducing agents, and because of our advanced understanding of the molecular biology and treatment of this leukemia, APL deserves to be presented and discussed in detail, apart from the other acute myeloid leukemias.

Cite

CITATION STYLE

APA

Wiernik, P. H., Gallagher, R. E., & Tallman, M. S. (2018). Acute promyelocytic leukemia. In Neoplastic Diseases of the Blood (pp. 409–463). Springer International Publishing. https://doi.org/10.1007/978-3-319-64263-5_21

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free